Literature DB >> 19650971

Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.

David M Yurek1, Anita M Flectcher, Tomasz H Kowalczyk, Linas Padegimas, Mark J Cooper.   

Abstract

Previously it was established that infusion of glial cell line-derived neurotrophic factor (GDNF) protein into grafts of embryonic dopamine cells has a neurotrophic effect on the grafted cells. In this study we used a nonviral technique to transfer the gene encoding for GDNF to striatal cells. Plasmid DNA encoding for GDNF was compacted into DNA nanoparticles (DNPs) by 10 kDa polyethylene glycol (PEG)-substituted lysine 30-mers (CK(30)PEG10k) and then injected into the denervated striatum of rats with unilateral 6-hydroxydopamine lesions. Sham controls were injected with saline. One week later, experimental animals received either a ventral mesencephalic (VM) tissue chunk graft or a cell suspension VM graft implanted into the denervated striatum. Grafts were allowed to integrate for 4-6 weeks and during this period we monitored spontaneous and drug-induced motor activity. Using stereological cell counting we observed a 16-fold increase in the number of surviving TH(+) cells within tissue chunk grafts placed into the striatum pretreated with pGDNF DNPs (14,923 +/- 4,326) when compared to grafts placed into striatum pretreated with saline (955 +/- 343). Similarly, we observed a sevenfold increase in the number of TH(+) cells within cell suspension grafts placed into the striatum treated with pGDNF DNPs when compared to cell suspension grafts placed into the saline dosed striatum. Behaviorally, we observed significant improvement in rotational scores and in spontaneous forepaw usage of the affected forelimb in grafted animals receiving prior treatment with compacted pGDNF DNPs when compared to grafted animals receiving saline control pretreatment. Data analysis for protein, morphological, and behavioral measures suggests that compacted pGDNF DNPs injected into the striatum can result in transfected cells overexpressing GDNF protein at levels that provide neurotrophic support for grafted embryonic dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650971      PMCID: PMC3031110          DOI: 10.3727/096368909X12483162196881

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  47 in total

1.  Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA.

Authors:  Xuguang Chen; Dianne M Kube; Mark J Cooper; Pamela B Davis
Journal:  Mol Ther       Date:  2007-12-04       Impact factor: 11.454

Review 2.  Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.

Authors:  Pedro R Lowenstein; Ronald J Mandel; Wei-Dong Xiong; Kurt Kroeger; Maria G Castro
Journal:  Curr Gene Ther       Date:  2007-10       Impact factor: 4.391

3.  Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles.

Authors:  T L Fink; P J Klepcyk; S M Oette; C R Gedeon; S L Hyatt; T H Kowalczyk; R C Moen; M J Cooper
Journal:  Gene Ther       Date:  2006-03-09       Impact factor: 5.250

4.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

5.  AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons.

Authors:  J D Elsworth; D E Redmond; C Leranth; K B Bjugstad; J R Sladek; T J Collier; S B Foti; R J Samulski; K P Vives; R H Roth
Journal:  Exp Neurol       Date:  2008-02-15       Impact factor: 5.330

6.  Long-term transgene expression in the central nervous system using DNA nanoparticles.

Authors:  David M Yurek; Anita M Fletcher; George M Smith; Kim B Seroogy; Assem G Ziady; Joseph Molter; Tomasz H Kowalczyk; Linas Padegimas; Mark J Cooper
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

7.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

8.  Efficacy of nonviral gene transfer in the canine brain.

Authors:  Seunguk Oh; G Elizabeth Pluhar; Elizabeth A McNeil; Kurt M Kroeger; Chunyan Liu; Maria G Castro; Pedro R Lowenstein; Andrew Freese; John R Ohlfest
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

9.  Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years.

Authors:  Ivar Mendez; Angel Viñuela; Arnar Astradsson; Karim Mukhida; Penelope Hallett; Harold Robertson; Travis Tierney; Renn Holness; Alain Dagher; John Q Trojanowski; Ole Isacson
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

10.  Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.

Authors:  Rafal Farjo; Jeff Skaggs; Alexander B Quiambao; Mark J Cooper; Muna I Naash
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  22 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

3.  Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells.

Authors:  Adarsha Koirala; Rasha S Makkia; Mark J Cooper; Muna I Naash
Journal:  Biomaterials       Date:  2011-09-01       Impact factor: 12.479

4.  The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Authors:  Timothy P Gilmour; Brigitte Piallat; Christopher A Lieu; Kala Venkiteswaran; Renuka Ramachandra; Anand N Rao; Andrew C Petticoffer; Matthew A Berk; Thyagarajan Subramanian
Journal:  Brain       Date:  2011-09-12       Impact factor: 13.501

Review 5.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 6.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Authors:  Adarsha Koirala; Shannon M Conley; Muna I Naash
Journal:  Biomaterials       Date:  2013-06-22       Impact factor: 12.479

7.  Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-α.

Authors:  J Chou; N H Greig; D Reiner; B J Hoffer; Y Wang
Journal:  Cell Transplant       Date:  2011-02-03       Impact factor: 4.064

8.  DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.

Authors:  Zongchao Han; Shannon M Conley; Rasha S Makkia; Mark J Cooper; Muna I Naash
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

9.  S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.

Authors:  Adarsha Koirala; Rasha S Makkia; Shannon M Conley; Mark J Cooper; Muna I Naash
Journal:  Hum Mol Genet       Date:  2013-01-18       Impact factor: 6.150

10.  Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson's disease.

Authors:  Zhongmei Chen; Yunpeng Yang; Xu Yang; Changqing Zhou; Fengqun Li; Peng Lei; Ling Zhong; Xin Jin; Guoguang Peng
Journal:  Neurol Sci       Date:  2013-01-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.